Trulieve Significantly Narrows Q3 Loss Thanks To Lower Operating Expenses

Florida-based cannabis company Trulieve Cannabis Corp. TRUL TCNNF reported its financial results Thursday for the third quarter, disclosing revenue of $275.2 million compared to $295.4 million in the same period a year ago and $282 million in the previous quarter.

"This year our team has done a phenomenal job executing on our plan to generate cash while making investments to support future growth," stated Kim Rivers, Trulieve CEO. "As demonstrated this quarter, Trulieve remains aligned with our shareholders, and is committed to strengthening our balance sheet with non-dilutive measures. With significant scale and service, strong cash generation, and a clearly defined strategy, Trulieve is best positioned for the coming wave of meaningful growth catalysts."

Q3 Financial Summary 

  • Gross profit amounted to $142.9 million, which compares to $168.7 million in the third quarter of 2022, and $142 in the second quarter of the year.
  • Net loss was $25 million, versus a net loss of $115.1 million a year ago, and net loss of $404 in the previous quarter.
  • Operating expenses were $120 million, down by 39% year-over-year, and 72% lower than in the second quarter of 2023.
  • Adjusted EBITDA was a gain of $78 million, or 28% of revenue, compared to adjusted EBITDA of $100 million in the third quarter of 2022, and $79 million in the second quarter of 2022.
  • In the quarter the company had a free cash flow of $87 million. Expect 2023 operating cash flow of at least $100 million and free cash flow of at least $70 million.
  • At the end of Sep. 30, the company reported cash of $200 million.

Price Action 

Trulieve shares closed Wednesday market session 3.16% higher at $4.9 per share.

Related Links:

Trulieve Donates $500K To Florida's Marijuana Legalization Ballot Initiative 

Cannabis Milestone: Over-The-Counter Medical Marijuana Launches In Georgia Pharmacies 

Photo: Courtesy of Mikhail Nilov via Pexels

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsPenny StocksSmall CapMarketsCannabis EarningsKim Riverspremium
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.


Loading...